An international randomised trial found fewer cases of acute kidney injury with cefazolin than with flucloxacillin or cloxacillin, while meeting its survival noninferiority threshold.
A Novartis oral pill for relapsing multiple sclerosis outperformed standard therapy in two large Phase III trials, and unlike a rival BTK inhibitor the FDA declined over liver concerns, it showed no liver safety signal. Here is what the REMODEL
The long-promised breakthrough in Alzheimer’s treatment is now facing a stark and uncomfortable reckoning. A sweeping new analysis of more than 20,000 patients has concluded that drugs designed to remove amyloid plaques
The promise was intoxicating. A weekly injection, a shrinking waistline, and the illusion—carefully marketed, widely consumed—that science had finally cracked obesity. Drugs like Ozempic and Wegovy surged into global consciousness, fueling a
In the brutal hierarchy of cancer biology, few mutations have mocked modern medicine quite like KRAS G12D — a molecular switch that drives some of the deadliest tumors while remaining considered “undruggable”
A quiet revolution is underway inside the US government’s most experimental health agency—one that, if successful, could render one of modern medicine’s most common surgeries obsolete. For decades, osteoarthritis has been treated
Indian deep-tech startup Accubits Invent Pvt Ltd has secured a patent for its revolutionary breath-based VOC sensor, marking a major leap forward in global healthcare innovation. The technology is capable of detecting
Washington — The Trump administration’s new $100,000 fee on every new H-1B petition, paired with a plan to tilt future selections toward higher-paid jobs, has upended hiring calendars from Silicon Valley to
Basel, Switzerland — Swiss pharmaceutical giant Roche is preparing to launch a pivotal late-stage clinical trial to test whether its experimental drug, trontinemab, can prevent the onset of Alzheimer’s disease symptoms in
Clinical trials lie at the heart of medical advancements. They offer crucial insights into the safety and efficacy of new treatments, from drugs to medical procedures. However, these studies often yield complex
“We are pleased to announce that we have received FDA approval to begin human clinical trials,” Elon Musk’s company said in a statement. It is emphasized that this is an important first
The third phase of clinical trials of the Cuban “Abdala” vaccine, which is anti-coronavirus, showed its 100% efficacy against severe cases of Covid disease. The results of clinical trials published by Prensa
Follow